n(g),n(g')-dimethyl-l-arginine has been researched along with Cardiovascular Stroke in 34 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current study evaluated level of serum asymmetric dimethylarginine (ADMA) and its association to cardiac biomarkers in thalassemia patients for early diagnosis of abnormality in myocardial infarction." | 7.88 | Association of serum asymmetric dimethyl-arginine and troponin I levels as a risk of myocardial infarction in thalassemia. ( Al-Malki, AL; Choudhry, H; Helmi, N; Kumosani, AT; Kumosani, TA; Moselhy, SS; Qari, M, 2018) |
| " The dimethylarginines asymmetric (ADMA) and symmetric dimethylarginine (SDMA) can impair the synthesis of NO and are elevated in patients with cardiovascular disease, including heart failure (HF)." | 7.85 | Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study. ( Atzler, D; Boeing, H; Böger, RH; Cordts, K; di Giuseppe, R; Menzel, J; Schwedhelm, E; Weikert, C; Wirth, J, 2017) |
| ": This study aimed to investigate the effects of salvianolic acid A (Sal A) on the time course of plasma and tissue dimethylarginine levels after myocardial infarction (MI) induced by left coronary artery ligation." | 7.79 | Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction. ( He, H; Jiang, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Yuan, L; Zhang, W, 2013) |
| "We aimed to investigate the effects of admission asymmetric dimethylarginine (ADMA) levels on myocardial perfusion and prognosis in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI)." | 7.77 | Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. ( Akgul, EO; Cayci, T; Covic, A; Demir, AD; Kanat, S; Kanbay, M; Maden, O; Ozcan, F; Ozlu, MF; Sen, N; Sokmen, E; Turak, O; Yaman, H, 2011) |
| "The study was designed to compare the response pattern of plasma l-arginine and methylarginines to stent placement in patients with or without ST segment elevation myocardial infarction (STEMI)." | 7.76 | Effects of stent implementation on plasma levels of asymmetric dimethylarginine in patients with or without ST-segment elevation acute myocardial infarction. ( Ajtay, Z; Awiszus, F; Bode-Böger, SM; Cziráki, A; Martens-Lobenhoffer, J; Németh, A; Sulyok, E; Szabados, S; Szabó, C, 2010) |
| "We sought to investigate the association between increased levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and total plasma homocysteinemia (tHcy) in patients with acute myocardial infarction (AMI)." | 7.74 | Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction. ( Cottin, Y; Duvillard, L; Gambert, P; Guilland, JC; Korandji, C; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M, 2007) |
| " We investigated whether plasma levels of the NOS inhibitor asymmetric dimethylarginine (ADMA), of symmetric dimethylarginine (SDMA) and of the nitrogen oxide substrate l-arginine can serve as additional staging biomarkers in stable coronary artery disease, non-ST-segment myocardial infarction (NSTEMI) and ST-segment myocardial infarction (STEMI)." | 7.74 | Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization. ( Frøbert, O; Hjortshøj, SP; Ravkilde, J; Simonsen, U, 2008) |
| "The relationship among the nitric oxide synthase (NOS) inhibitor [asymmetric dimethylarginine (ADMA)], NOS cofactor [tetrahydrobiopterin (BH(4))], and superoxide anion in the patients with acute myocardial infarction (AMI) is still unknown." | 7.74 | Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. ( Akasaka, T; Kaji, S; Kajiya, F; Mochizuki, S; Ogasawara, Y; Tanemoto, K; Yada, T; Yoshida, K, 2007) |
| "Our aim was to evaluate early initiated one month n-3 polyunsaturated fatty acids (PUFA) supplementation effects on ultrasound indices of endothelial function and serum asymmetric dimethylarginine (ADMA) levels in patients with acute myocardial infarction (AMI)." | 5.15 | N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction. ( Chmiel, A; Gąsior, Z; Gieszczyk, K; Haberka, M; Janowska, J; Mizia, M; Mizia-Stec, K; Zahorska-Markiewicz, B, 2011) |
| "The current study evaluated level of serum asymmetric dimethylarginine (ADMA) and its association to cardiac biomarkers in thalassemia patients for early diagnosis of abnormality in myocardial infarction." | 3.88 | Association of serum asymmetric dimethyl-arginine and troponin I levels as a risk of myocardial infarction in thalassemia. ( Al-Malki, AL; Choudhry, H; Helmi, N; Kumosani, AT; Kumosani, TA; Moselhy, SS; Qari, M, 2018) |
| " The dimethylarginines asymmetric (ADMA) and symmetric dimethylarginine (SDMA) can impair the synthesis of NO and are elevated in patients with cardiovascular disease, including heart failure (HF)." | 3.85 | Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study. ( Atzler, D; Boeing, H; Böger, RH; Cordts, K; di Giuseppe, R; Menzel, J; Schwedhelm, E; Weikert, C; Wirth, J, 2017) |
| "Single nucleotide polymorphisms (SNPs) contributing to l-arginine, ADMA, and SDMA, at genome-wide significance, were applied to the CARDIoGRAMplusC4D 1000 Genomes-based genome-wide association study IHD case (n=60,801, ~70% myocardial infarction)-control (n=123,504) study." | 3.83 | Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study. ( Au Yeung, SL; Lam, HS; Lin, SL; Schooling, CM, 2016) |
| ": This study aimed to investigate the effects of salvianolic acid A (Sal A) on the time course of plasma and tissue dimethylarginine levels after myocardial infarction (MI) induced by left coronary artery ligation." | 3.79 | Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction. ( He, H; Jiang, H; Li, X; Liu, X; Liu, Y; Wang, H; Wang, S; Yuan, L; Zhang, W, 2013) |
| "A low concentration of nitric oxide associated with a high concentration of asymmetric dimethylarginine (ADMA) can explain the lack of ischemic cardioprotection observed in the presence of hypercholesterolemia." | 3.79 | High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats. ( Casella-Filho, A; Chagas, AC; da-Luz, PL; Dourado, PM; Landim, MB, 2013) |
| "We determined N-Hcy-Lys in serum and a NO syntase inhibitor asymmetric dimethylarginine (ADMA), as well as symmetric dimethylarginine (SDMA) and glutathione in plasma by high performance liquid chromatography in 52 consecutive patients with acute myocardial infarction (AMI) recruited within the first 12 h following onset of chest pain." | 3.77 | Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation. ( Głowacki, R; Heród, P; Jakubowski, H; Kazek, G; Machnik, A; Undas, A; Zaąbczyk, M, 2011) |
| "Induced arginase I after myocardial infarction may deplete the arginine pool." | 3.77 | Serum levels of arginase I are associated with left ventricular function after myocardial infarction. ( Bekpinar, S; Develi, S; Gurdol, F; Unlucerci, Y; Yilmaz, A, 2011) |
| "We aimed to investigate the effects of admission asymmetric dimethylarginine (ADMA) levels on myocardial perfusion and prognosis in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI)." | 3.77 | Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. ( Akgul, EO; Cayci, T; Covic, A; Demir, AD; Kanat, S; Kanbay, M; Maden, O; Ozcan, F; Ozlu, MF; Sen, N; Sokmen, E; Turak, O; Yaman, H, 2011) |
| "The study was designed to compare the response pattern of plasma l-arginine and methylarginines to stent placement in patients with or without ST segment elevation myocardial infarction (STEMI)." | 3.76 | Effects of stent implementation on plasma levels of asymmetric dimethylarginine in patients with or without ST-segment elevation acute myocardial infarction. ( Ajtay, Z; Awiszus, F; Bode-Böger, SM; Cziráki, A; Martens-Lobenhoffer, J; Németh, A; Sulyok, E; Szabados, S; Szabó, C, 2010) |
| "We sought to investigate the association between increased levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and total plasma homocysteinemia (tHcy) in patients with acute myocardial infarction (AMI)." | 3.74 | Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction. ( Cottin, Y; Duvillard, L; Gambert, P; Guilland, JC; Korandji, C; Moreau, D; Rochette, L; Sicard, P; Vergely, C; Zeller, M, 2007) |
| " We tested whether the plasma levels of (1) asymmetric dimethylarginine (ADMA), (2) cortisol/cortisone (Cl/Cn) ratio, and (3) C-peptide predicted glycemic status, coronary artery disease, and death or myocardial infarction (MI) in a nested case-control cohort (N = 850) with normal fasting glucose (< 110 mg/dL), impaired fasting glucose (110-125), or diabetic (> or = 126) status." | 3.74 | Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk? ( Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Kushnir, MM; May, HT; Muhlestein, JB; Nielson, R; Pasquali, M; Roberts, WL; Rockwood, AL; Schwarz, EL, 2007) |
| " We investigated whether plasma levels of the NOS inhibitor asymmetric dimethylarginine (ADMA), of symmetric dimethylarginine (SDMA) and of the nitrogen oxide substrate l-arginine can serve as additional staging biomarkers in stable coronary artery disease, non-ST-segment myocardial infarction (NSTEMI) and ST-segment myocardial infarction (STEMI)." | 3.74 | Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization. ( Frøbert, O; Hjortshøj, SP; Ravkilde, J; Simonsen, U, 2008) |
| "The relationship among the nitric oxide synthase (NOS) inhibitor [asymmetric dimethylarginine (ADMA)], NOS cofactor [tetrahydrobiopterin (BH(4))], and superoxide anion in the patients with acute myocardial infarction (AMI) is still unknown." | 3.74 | Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. ( Akasaka, T; Kaji, S; Kajiya, F; Mochizuki, S; Ogasawara, Y; Tanemoto, K; Yada, T; Yoshida, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 22 (64.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, E | 1 |
| Ruiz-Canela, M | 1 |
| Hu, FB | 1 |
| Clish, CB | 1 |
| Corella, D | 1 |
| Salas-Salvadó, J | 1 |
| Hruby, A | 1 |
| Fitó, M | 1 |
| Liang, L | 1 |
| Toledo, E | 1 |
| Ros, E | 1 |
| Estruch, R | 1 |
| Gómez-Gracia, E | 1 |
| Lapetra, J | 1 |
| Arós, F | 1 |
| Romaguera, D | 1 |
| Serra-Majem, L | 1 |
| Guasch-Ferré, M | 1 |
| Wang, DD | 1 |
| Martínez-González, MA | 1 |
| Pessoa, FG | 1 |
| Mady, C | 1 |
| Fonseca, KCB | 1 |
| de Oliveira-Fonoff, AM | 1 |
| Salemi, VMC | 1 |
| Jordão, MR | 1 |
| Fernandes, F | 1 |
| Ramires, FJA | 1 |
| Helmi, N | 1 |
| Choudhry, H | 1 |
| Qari, M | 1 |
| Kumosani, TA | 1 |
| Al-Malki, AL | 1 |
| Moselhy, SS | 1 |
| Kumosani, AT | 1 |
| He, H | 2 |
| Li, X | 2 |
| Wang, H | 2 |
| Zhang, W | 2 |
| Jiang, H | 1 |
| Wang, S | 2 |
| Yuan, L | 2 |
| Liu, Y | 1 |
| Liu, X | 2 |
| Landim, MB | 1 |
| Dourado, PM | 1 |
| Casella-Filho, A | 1 |
| Chagas, AC | 1 |
| da-Luz, PL | 1 |
| Plicner, D | 1 |
| Mazur, P | 1 |
| Sadowski, J | 1 |
| Undas, A | 2 |
| Zhang, HC | 1 |
| Liu, W | 1 |
| Yuan, HT | 1 |
| Tang, YS | 1 |
| Stamboul, K | 1 |
| Lorin, J | 1 |
| Lorgis, L | 2 |
| Guenancia, C | 1 |
| Beer, JC | 2 |
| Touzery, C | 1 |
| Rochette, L | 3 |
| Vergely, C | 3 |
| Cottin, Y | 3 |
| Zeller, M | 3 |
| Borgeraas, H | 2 |
| Hertel, JK | 2 |
| Seifert, R | 2 |
| Berge, RK | 1 |
| Bohov, P | 1 |
| Ueland, PM | 1 |
| Nygård, O | 2 |
| Hjelmesæth, J | 2 |
| Svingen, GF | 1 |
| Pedersen, ER | 1 |
| Wirth, J | 1 |
| Atzler, D | 1 |
| di Giuseppe, R | 1 |
| Cordts, K | 1 |
| Menzel, J | 1 |
| Böger, RH | 1 |
| Boeing, H | 1 |
| Weikert, C | 1 |
| Schwedhelm, E | 1 |
| Au Yeung, SL | 1 |
| Lin, SL | 1 |
| Lam, HS | 1 |
| Schooling, CM | 1 |
| Cavusoglu, E | 1 |
| Ruwende, C | 1 |
| Chopra, V | 1 |
| Yanamadala, S | 1 |
| Eng, C | 1 |
| Pinsky, DJ | 1 |
| Marmur, JD | 1 |
| Ajtay, Z | 1 |
| Németh, A | 1 |
| Sulyok, E | 1 |
| Cziráki, A | 1 |
| Szabados, S | 1 |
| Martens-Lobenhoffer, J | 1 |
| Awiszus, F | 1 |
| Szabó, C | 1 |
| Bode-Böger, SM | 1 |
| Haberka, M | 1 |
| Mizia-Stec, K | 1 |
| Mizia, M | 1 |
| Janowska, J | 1 |
| Gieszczyk, K | 1 |
| Chmiel, A | 1 |
| Zahorska-Markiewicz, B | 1 |
| Gąsior, Z | 1 |
| Zaąbczyk, M | 1 |
| Głowacki, R | 1 |
| Machnik, A | 1 |
| Heród, P | 1 |
| Kazek, G | 1 |
| Jakubowski, H | 1 |
| Yilmaz, A | 2 |
| Bekpinar, S | 2 |
| Unlucerci, Y | 2 |
| Gurdol, F | 2 |
| Umman, B | 1 |
| Lu, TM | 2 |
| Chung, MY | 1 |
| Lin, CC | 1 |
| Hsu, CP | 1 |
| Lin, SJ | 2 |
| Develi, S | 1 |
| Sen, N | 1 |
| Ozlu, MF | 1 |
| Akgul, EO | 1 |
| Kanat, S | 1 |
| Cayci, T | 1 |
| Turak, O | 1 |
| Yaman, H | 1 |
| Sokmen, E | 1 |
| Ozcan, F | 1 |
| Maden, O | 1 |
| Demir, AD | 1 |
| Covic, A | 1 |
| Kanbay, M | 1 |
| Bergheanu, SC | 1 |
| van der Laarse, A | 1 |
| van der Bom, JG | 1 |
| van der Hoeven, BL | 1 |
| le Cessie, S | 1 |
| de Jong, MG | 1 |
| Liem, SS | 1 |
| Schalij, MJ | 1 |
| Jukema, JW | 1 |
| Yucel, H | 1 |
| Ozaydin, M | 1 |
| Dogan, A | 1 |
| Erdogan, D | 1 |
| Turker, Y | 1 |
| Ceyhan, BM | 1 |
| Sutcu, R | 1 |
| Ding, YA | 1 |
| Lee, WS | 1 |
| Tai, HC | 1 |
| Tsuda, K | 1 |
| Nishio, I | 1 |
| Valkonen, VP | 1 |
| Laaksonen, R | 1 |
| Bae, SW | 1 |
| Stühlinger, MC | 1 |
| Yoo, HS | 1 |
| Yu, KH | 1 |
| Park, HK | 1 |
| Choi, BY | 1 |
| Lee, YS | 1 |
| Pachinger, O | 1 |
| Choi, YH | 1 |
| Lee, SH | 1 |
| Park, JE | 1 |
| Korandji, C | 2 |
| Guilland, JC | 2 |
| Sicard, P | 2 |
| Duvillard, L | 2 |
| Gambert, P | 2 |
| Moreau, D | 2 |
| Anderson, JL | 1 |
| Carlquist, JF | 1 |
| Roberts, WL | 1 |
| Horne, BD | 1 |
| May, HT | 1 |
| Schwarz, EL | 1 |
| Pasquali, M | 1 |
| Nielson, R | 1 |
| Kushnir, MM | 1 |
| Rockwood, AL | 1 |
| Bair, TL | 1 |
| Muhlestein, JB | 1 |
| Frøbert, O | 1 |
| Hjortshøj, SP | 1 |
| Simonsen, U | 1 |
| Ravkilde, J | 1 |
| Yada, T | 1 |
| Kaji, S | 1 |
| Akasaka, T | 1 |
| Mochizuki, S | 1 |
| Ogasawara, Y | 1 |
| Tanemoto, K | 1 |
| Yoshida, K | 1 |
| Kajiya, F | 1 |
| Kielstein, JT | 1 |
| Sydow, K | 1 |
| Thum, T | 1 |
| Lagrost, AC | 1 |
| Leong, T | 1 |
| Zylberstein, D | 1 |
| Graham, I | 1 |
| Lissner, L | 1 |
| Ward, D | 1 |
| Fogarty, J | 1 |
| Bengtsson, C | 1 |
| Björkelund, C | 1 |
| Thelle, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Double Blind Study of the Effects of Homocysteine Lowering Therapy on Mortality and Cardiac Events in Patients Undergoing Coronary Angiography[NCT00354081] | Phase 3 | 3,096 participants (Actual) | Interventional | 1999-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for n(g),n(g')-dimethyl-l-arginine and Cardiovascular Stroke
| Article | Year |
|---|---|
A novel metabolic balance model for describing the metabolic disruption of and interactions between cardiovascular-related markers during acute myocardial infarction.
Topics: Acute Disease; Adenosine Triphosphate; Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascula | 2013 |
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; St | 2004 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Cardiovascular Stroke
| Article | Year |
|---|---|
[Salvia Miltiorrhiza reduces plasma levels of asymmetric ADMA in patients with non-ST elevation myocardial infarction undergoing percutaneous coronary intervention].
Topics: Arginine; Drugs, Chinese Herbal; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; | 2014 |
N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Blood Flow Velocity; Dietary Supplements; Dilatation | 2011 |
30 other studies available for n(g),n(g')-dimethyl-l-arginine and Cardiovascular Stroke
| Article | Year |
|---|---|
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; C | 2017 |
Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function.
Topics: Animals; Apoptosis; Arginine; Collagen; Diastole; Erythropoietin; Glutathione; Heart; Hematocrit; He | 2018 |
Association of serum asymmetric dimethyl-arginine and troponin I levels as a risk of myocardial infarction in thalassemia.
Topics: Arginine; Biomarkers; Case-Control Studies; Creatine Kinase, MB Form; Humans; L-Lactate Dehydrogenas | 2018 |
Effects of salvianolic acid A on plasma and tissue dimethylarginine levels in a rat model of myocardial infarction.
Topics: Amidohydrolases; Animals; Arginine; Caffeic Acids; Chromatography, High Pressure Liquid; Creatinine; | 2013 |
High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats.
Topics: Animals; Arginine; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Hypercholesterolemia; | 2013 |
Asymmetric dimethylarginine and oxidative stress following coronary artery bypass grafting: associations with postoperative outcome.
Topics: Aged; Arginine; Coronary Artery Bypass; Dinoprost; Female; Hospital Mortality; Humans; Male; Middle | 2014 |
Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Biomarkers; Chromatography, High Pressure Li | 2015 |
Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
Topics: Aged; Arginine; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; P | 2016 |
Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris.
Topics: Angina, Stable; Arginine; Body Mass Index; Female; Humans; Male; Middle Aged; Myocardial Infarction; | 2016 |
Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
Topics: Adult; Aged; Arginine; Biomarkers; Feeding Behavior; Female; Germany; Heart Failure; Humans; Male; M | 2017 |
Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study.
Topics: Arginine; Female; Genome-Wide Association Study; Humans; Male; Mediator Complex; Mendelian Randomiza | 2016 |
Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Arginine; Biomarkers; Coronary Angiography; Follow- | 2009 |
Effects of stent implementation on plasma levels of asymmetric dimethylarginine in patients with or without ST-segment elevation acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Arginine; Case-Control Studies; Coronary Angiography; Female; Humans | 2010 |
Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation.
Topics: Arginine; Autoantibodies; Dipeptides; Endothelium; Female; Fibrinolysis; Humans; Male; Middle Aged; | 2011 |
High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction.
Topics: Angioplasty; Arginine; Biomarkers; Blood Circulation; Electrocardiography; Female; Humans; Lipid Met | 2011 |
Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Albuminuria; Arginine; Biomarkers; Chi-Square Distribution; Chromatography, | 2011 |
Serum levels of arginase I are associated with left ventricular function after myocardial infarction.
Topics: Arginase; Arginine; Case-Control Studies; Humans; Myocardial Infarction; Stroke Volume; Ventricular | 2011 |
Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
Topics: Aged; Arginine; Coronary Angiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardi | 2011 |
Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction.
Topics: Aged; Arginine; Biomarkers; Blood Pressure; Body Mass Index; Circadian Rhythm; Cross-Sectional Studi | 2011 |
Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
Topics: Arginine; Case-Control Studies; Coronary Angiography; Coronary Circulation; Demography; Female; Hemo | 2012 |
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pr | 2003 |
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemi | 2004 |
Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Topics: Adult; Aged; alpha-Tocopherol; Angina, Unstable; Angioplasty, Balloon, Coronary; Arginine; C-Reactiv | 2005 |
Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
Topics: Aged; Arginine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial In | 2007 |
Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
Topics: Arginine; Biomarkers; Blood Glucose; C-Peptide; Case-Control Studies; Coronary Disease; Cortisone; D | 2007 |
Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
Topics: Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary | 2008 |
Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments.
Topics: Adult; Aged; Arginine; Biopterins; Case-Control Studies; Drug Therapy; Endothelium, Vascular; Female | 2007 |
Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Topics: Arginine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Myocardial Infarction; Nitric Oxide | 2007 |
Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Humans; Ma | 2008 |
Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Topics: Adult; Arginine; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Longit | 2008 |